Ability of a screening test to diagnose true positive refers to: March 2010
**Question:** Ability of a screening test to diagnose true positive refers to: March 2010
**Core Concept:**
In medical diagnosis, a true positive refers to a test result that correctly identifies an individual with a specific disease or condition. A screening test aims to identify individuals who may have a disease or condition, even if they are asymptomatic or have early-stage symptoms. The ability of a screening test to correctly identify true positives is crucial for early intervention and treatment, as well as preventing unnecessary false alarms and overdiagnosis.
**Why the Correct Answer is Right:**
The correct answer refers to the sensitivity of a screening test, which is the proportion of true positives among all individuals with the disease or condition. Sensitivity represents the test's ability to correctly identify those who truly have the disease or condition. In this context, a true positive is an individual who is correctly identified by the screening test as having the disease or condition.
**Why Each Wrong Option is Incorrect:**
A. Specificity: This refers to the proportion of true negatives among all individuals without the disease or condition. It is the test's ability to correctly identify those who do not have the disease or condition. In this context, false positives are incorrectly identified by the screening test as having the disease or condition, not true positives.
B. Positive Predictive Value (PPV): This represents the probability that a positive screening test result indicates the presence of the disease or condition, considering the prevalence of the disease or condition in the population being screened. PPV is not directly related to identifying true positives, but rather the likelihood that a positive test result implies the disease is present.
C. Negative Predictive Value (NPV): This represents the probability that a negative screening test result indicates the absence of the disease or condition, considering the prevalence of the disease or condition in the population being screened. NPV is not directly related to identifying true positives, but rather the likelihood that a negative test result implies the disease is absent.
D. False Positive Rate (FPR): This represents the proportion of false positives among all positive test results. In this context, false positives are incorrectly identified by the screening test as having the disease or condition, not true positives.
**Clinical Pearl:**
In clinical practice, understanding the sensitivity and specificity of a screening test is crucial for appropriate patient management. Sensitivity and specificity together provide important information about a test's overall performance in identifying both true positives and true negatives. However, in this specific question, we focus on true positives, which is the correct answer's concept.
**Correct Answer:**
The correct answer is **D. False Positive Rate (FPR)**. The false positive rate represents the proportion of false positives among all positive test results. False positives occur when a person without the disease or condition is incorrectly identified as having it. In this context, false positives are incorrectly identified as having the disease or condition by the screening test. A low false positive rate indicates better test performance in identifying true positives (individuals with the disease or condition).
**Why False Positive Rate is Crucial:**
A low false positive rate is crucial because it